29N-70109-77875
3 vaccinations
1 coded response
38 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 802 / CO
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-28
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Registered in v-safe
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-11
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-19
- 2021-10-19
-
2021-12-07
Dose 3 — Pfizer-BioNTech
- 2021-12-07
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-03-08
- 2022-06-07
-
2022-12-07
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Pregnancy (I can't remember if I reported that already)MedDRA releases: 2024-11 · check-in free text available
-
2022-12-07
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-28 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-07 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Symptoms: Pregnancy (I can't remember if I reported that already)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release